About Us
OncoNano Medicine was established to improve the lives of cancer patients.
Our team of scientists, physicians and advisors is pioneering the next frontier of cancer therapeutics using our proprietary nanotechnology platform. OncoNano's ON-BOARD™ platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to maximize the intratumoral delivery of its therapeutic cargoes. OncoNano is passionate about generating a robust oncology pipeline to advance more precise therapies and better patient outcomes.
Leadership
Board of Directors
Brett P. Giroir, MD Chairman
Kartik Krishnan, MD, PhD
Gina Guillem Jones, MMS, PhD
Benjamin Qui, CFA, CMA
Scientific Advisory Board
Charles Balch, MD, Chairman
Jinming Gao, PhD
John Niederhuber, MD
Paul Bunn, MD
Baran Sumer, MD
Raphael Pollock, MD, PhD
Alexander Eggermont, MD, PhD